Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Fumbler's Profile
Displaying 201-250 of 265 result(s).
CYDY CytoDyn Inc
07/28/2020 5:44:02 PM
There are investors on the board, i (2)
CYDY CytoDyn Inc
07/22/2020 12:36:55 PM
It's called 'transparency', he had (2)
CYDY CytoDyn Inc
07/17/2020 11:18:54 PM
Bubonic Plague might be another ind (2)
CYDY CytoDyn Inc
07/10/2020 2:19:45 PM
And it will be substantial, no doub (1)
CYDY CytoDyn Inc
07/10/2020 2:14:29 PM
Vegas is nice this time of year...i (1)
CYDY CytoDyn Inc
07/04/2020 12:40:52 AM
I see what you did there.
CYDY CytoDyn Inc
06/22/2020 2:02:20 PM
$11.50
CYDY CytoDyn Inc
06/20/2020 1:00:20 PM
How about being acquired by Regener (1)
CYDY CytoDyn Inc
06/19/2020 9:28:49 PM
Dr. Patterson's presentation is alr (2)
CYDY CytoDyn Inc
06/19/2020 1:07:04 PM
I think Dr. Patterson let the cat a
CYDY CytoDyn Inc
06/16/2020 3:56:42 PM
Here's a spitball exercise for you. (4)
CYDY CytoDyn Inc
06/15/2020 6:06:51 PM
If you look at 'exclusion criteria' (2)
CYDY CytoDyn Inc
06/09/2020 1:48:32 AM
This paper is calling leronlimab an
CYDY CytoDyn Inc
06/02/2020 7:22:44 PM
Today's presentation.... https://ww (5)
CYDY CytoDyn Inc
05/26/2020 12:28:24 PM
The initial BLA was a combo therapy
CYDY CytoDyn Inc
05/25/2020 8:54:11 PM
It states BLA, HIV monotherapy.
CYDY CytoDyn Inc
05/25/2020 12:38:09 AM
Here's an update to that case. Dr. (1)
CYDY CytoDyn Inc
05/22/2020 11:46:41 PM
Give the CytoDyn people some space! (5)
CYDY CytoDyn Inc
05/21/2020 1:56:29 AM
How else would a poor doctor turned (1)
CYDY CytoDyn Inc
05/21/2020 1:49:52 AM
The situation in Mexico may be much
CYDY CytoDyn Inc
05/18/2020 8:40:07 PM
I've got the feeling that FDA recom (3)
CYDY CytoDyn Inc
05/18/2020 12:25:09 AM
Dr Patterson knows his results from
CYDY CytoDyn Inc
05/18/2020 12:00:52 AM
Yes, they both make great placebos! (2)
CYDY CytoDyn Inc
05/17/2020 11:59:06 PM
IncellDX performs diagnostic analys (2)
CYDY CytoDyn Inc
05/10/2020 6:54:25 PM
The White House will step in and he (1)
CYDY CytoDyn Inc
05/08/2020 6:05:55 PM
Yep. Baricitinib contraindications: (1)
CYDY CytoDyn Inc
05/07/2020 9:28:52 PM
Here's the comment from NYT. I Inpa (4)
CYDY CytoDyn Inc
05/07/2020 2:53:29 PM
Unfortunately the goalposts are bei (12)
CYDY CytoDyn Inc
05/07/2020 2:33:48 PM
I would think that to be part of th
CYDY CytoDyn Inc
05/07/2020 2:23:59 PM
They don't need the money to make t
CYDY CytoDyn Inc
05/07/2020 12:30:16 AM
It's listed in the 'drug candidates
CYDY CytoDyn Inc
05/05/2020 8:52:19 PM
Maybe he's not getting paid to know
CYDY CytoDyn Inc
05/02/2020 3:28:02 PM
No responses, just the one like.
CYDY CytoDyn Inc
05/02/2020 2:24:21 PM
I posted this Twitter notification (1)
CYDY CytoDyn Inc
05/01/2020 7:55:20 PM
That's true, FDA did help the littl (1)
CYDY CytoDyn Inc
04/29/2020 8:10:28 PM
It's an anti-viral and in the words
CYDY CytoDyn Inc
04/29/2020 7:16:32 PM
"Under the agreement between Gilead (1)
CYDY CytoDyn Inc
04/29/2020 6:46:29 PM
And Fauci calls this the standard o
CYDY CytoDyn Inc
04/29/2020 1:37:47 AM
I don't know if this has ever been (4)
CYDY CytoDyn Inc
04/29/2020 12:05:49 AM
You are apparently not the only one (2)
CYDY CytoDyn Inc
04/28/2020 5:14:40 PM
Trodelvy has been approved for trea
CYDY CytoDyn Inc
04/28/2020 5:01:00 PM
LOL. My second investment reported
CYDY CytoDyn Inc
04/28/2020 4:55:00 PM
With a mortality rate of 50% in the
CYDY CytoDyn Inc
04/27/2020 9:10:17 PM
Dr. Patterson's comments are absolu (5)
CYDY CytoDyn Inc
04/25/2020 4:38:16 PM
This one drug could save trillions
CYDY CytoDyn Inc
04/25/2020 12:14:36 AM
Christmas may come early this year. (1)
CYDY CytoDyn Inc
04/24/2020 10:33:13 PM
He was discussing mainly vaccine ef (6)
CYDY CytoDyn Inc
04/24/2020 10:20:22 PM
I don't know if anyone watched the (4)
CYDY CytoDyn Inc
04/22/2020 1:50:56 PM
Dr. Yo is most exited about remdesi (2)
CYDY CytoDyn Inc
04/21/2020 12:48:39 PM
Here's some info based on an articl
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Janice Page Sells $484K Worth of American Eagle Stock: Insight
  • The Impressive Growth of Ameriprise Financial Stock Over Time
  • Rocket Companies Seizes Opportunities Amid Growing Economic Signals
  • NVIDIA's Competitive Edge: An In-Depth Industry Review
  • Understanding TTM Technologies' Strong Financial Growth Potential
  • An In-Depth Analysis of Microsoft and Its Software Rivals
  • Investment Success: How Your $1000 Grew in Pure Storage Today
  • Aston Martin and Pirelli Collaborate on Advanced Tyre Technology
  • Valicy Gaming Unveils New Brand Focused on Innovative Solutions
  • Dave & Buster's Prepares for Earnings Announcement
  • Jeff Kirk Joins Robots & Pencils as EVP of Applied AI Role
  • North Dakota and Savvas Learning Enhance Career Path Education
  • GME Supply Expands Horizons with Wayne Enterprises Acquisition
  • RiskThinking.ai Chosen for National Climate Stress Test Analysis
  • uLab Systems and Biolux Team Up to Redefine Orthodontics
  • Datalink Networks Unveils Microsoft Teams Voice Solution for Growth
  • Celebrating 75 Years: Kitchell's Impact on Community and Service
  • Examining Amazon's Competitive Edge in Retail Landscape
  • Exploring Trends in Options Trading for Warner Bros. Discovery
  • Smart Investments: A Deep Dive into Fortinet's Options Trends
  • Duolingo's Market Dynamics: Investors Gear Up for Change
  • Market Surge: Notable Stocks Soaring This Week
  • Analyzing Apple’s Dominance Against Competitors in Tech Hardware
  • Understanding the Short Interest Trends for Kirby Corp (KEX)
  • Malcolm Ian Grant Gilchrist Executes Stock Options at Liberty Media
  • Carpenter Technology's Insider Activity Reveals Strategic Moves
  • Motorola Solutions Insider Options Exercise Reflects Confidence
  • GigaCloud Tech CEO's Significant Stock Transaction Sparks Interest
  • Insider Confidence: A Bold $865K Investment in Salesforce
  • CoreCivic Insider's $442K Stock Sale: Implications and Insights
  • HII Boosts Shipbuilding Efficiency Through Strategic Partnerships
  • CORSTAR Holdings Reports $6.40M CorVel Stock Transfer
  • Join Zealand Pharma's Upcoming Capital Markets Day in London
  • Patrick Sean Buckley Sells $1M in Magnite Stock: Insights
  • InnovAge Earns Recognition as a Top Workplace in Aging Services
  • Douglas Comings Sells $2.5 Million in Brinker International Stock
  • Crucial Steps Against Illegal E-Cigarettes to Protect Youth
  • Black Stone Minerals CEO Makes Huge Stock Purchase of $306K
  • Explore the Powerful Features of the 2026 Ford F-250 Super Duty
  • Norman Wright Boosts Confidence in Option Care Health with $99K Buy
  • Projected Growth of Medical Sensors Market to Reach $4.48B
  • Insider Trading Highlights for Paylocity Holding Shares
  • Gravity Achieves Recognition in Carbon Management Innovation
  • Brandon Williams Steps Up as Leader of Wealth Management Team
  • Appspace Expands Reach with Igloo Software Acquisition
  • Mesirow Earns Spot on Crain's Best Places to Work List
  • EqualizeRCM Expands Service Offerings with New Acquisition
  • Explore Wellness and Relaxation at Marriott Bonvoy Resorts
  • Discover Igniton Quantum Wellness with Gaia's Latest Supplements
  • Katten Strengthens Private Credit Team with Expert R. Kader Crawford
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site